DEF 14A

Company

Indivior Pharmaceuticals, Inc.

Filed

March 27, 2026

Period of Report

May 13, 2026

Accession Number

0001104659-26-035480

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →